An interventional study of Living Cancer CALM education intervention in Breast Cancer, sponsored by Case Comprehensive Cancer Center. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-30.
Sponsored by Case Comprehensive Cancer Center · Not applicable, Interventional, and Supportive care
This study is for participants with a history of breast cancer. The purpose of this study is to determine if Case Western Reserve University Teaching Kitchen is able to deliver an out patient culinary medicine intervention in-person and via Zoom. Participants will then apply the culinary and lifestyle cancer risk reduction strategies in between sessions. Surveys will be collected before and after the program.
There are gaps in care after cancer treatment, Many breast cancer survivors face ongoing challenges related to weight gain, metabolic dysfunction, reduced quality of life, and increased risk of chronic disease after finishing cancer treatment. Culinary interventions focusing on participants with breast cancer and survivors have been growing in popularity and and these studies show the positive effects that a healthy diet can have on the risk and recurrence, mortality, and quality of life.
These studies have laid the groundwork to develop the Cancer CALM (Culinary And Lifestyle Medicine) program for healthcare providers in training and serves as an education intervention. This program provides dietary and lifestyle cancer risk reduction (CRR) strategies using a lecture series and hands-on culinary experience. The long-term goal of this is to give future physicians the knowledge to use these strategies into their future clinical practice.
The purpose of this study is to determine if its is possible to deliver the Living Cancer Calm intervention and have participants apply risk reduction strategies between sessions. This study includes 4 in-person culinary medicine sessions and 4 virtual group nutrition education sessions. Participants will be asked to complete surveys before and after the program. 44 participants will be recruited in this study.
14,825 studies on the registry are indexed under Breast Neoplasms; 3,319 are open to participants now.
This study's planned enrollment of 44 is below the median of 72 across 10,896 interventional studies indexed under Breast Neoplasms.
Browse Breast Neoplasms studies →Case Comprehensive Cancer Center is the lead sponsor of 494 studies on the registry; 61 are open to participants now.
Of its 75 completed or terminated interventional studies of FDA-regulated products, 46 (61%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Eight 90 minute lessons delivered bi-weekly in the evenings in a hybrid format with alternating virtual and in-person lessons.
Behavioral: Living Cancer CALM education intervention
Eight 90-minute lessons delivered bi-weekly in the evenings in a hybrid format with alternating virtual and in-person lessons with each lesson focusing on specific nutrition and culinary skills.
Rates of recruitment
Feasibility and acceptability will be evaluated using rates of recruitment
Time frame: up to 18 weeks
Rates of retention
Feasibility and acceptability will be evaluated using rates of retention
Time frame: up to 18 weeks
Rates of attendance
Feasibility and acceptability will be evaluated using rates of attendance
Time frame: up to 18 weeks
Acceptability scores
Feasibility and acceptability will be evaluated using acceptability scores
Time frame: up to 18 weeks
Plan to share: No — This is an investigator initiated pilot trial examining the feasibility an acceptability of a culinary medicine intervention. When sharing IPD via open access, the lack of restrictions leads to greater risk of re-identifying individuals. Data could be inappropriately merged with other data to facilitate re-identification. Our small study population makes this more likely. On the other hand, sharing IPD via controlled access is burdensome. It requires resources that we do not have (setting up the infrastructure and policies, administering and reviewing data requests, preparing data and distributing data). The personnel time for such an endeavor was not budgeted, nor do we have the financial resources to include it in the study budget.
No publications or documents are linked to this record.
Start is estimated for Nov 2026; primary completion for Jun 2027, 6 months later.
Of 2,661 non-industry interventional studies with no phase under Breast Neoplasms, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 66. This study's planned 6 months is below that.
Counting every sponsor, half of 2,771 studies reached it within 33 months; a quarter within 15 and three quarters within 66.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Case Comprehensive Cancer Center →